Global market for treatments for syndromes of dementia & movement disorders to grow to $16.7 bn. in 2017

The global market for treatments for syndromes of dementia and movement disorders was valued at $10.5 billion in 2011 and should reach $11.1 billion in 2012. Total market value is expected to reach $16.7 billion in 2017 increasing at a five-year compound annual growth rate (CAGR) of 8.5%.

Learn about the present and future strategies within the neurodegenerative disorder market, which includes treatments and therapies for progressive dementia, progressive dementia with other neurological abnormalities and movement disorders. Market gains, setbacks, the regulatory environment, new developments and company profiles are also discussed in this report...  

Use this report to:

• Gain an overview of the current and future characteristics of the global markets for treatments for syndromes of dementia and movement disorders
• Breakdown revenues by neurodegenerative disease and primary clinical/pathological feature
• Review applications for treatments and therapeutic technologies for syndromes of dementia and movement disorders
• Identify the major players in the industry most likely to compete well now and into the future
• Review patent information relevant to the industry.

To provide further information about this report we offer a Complimentary Introduction, available from our Website. To download, simply click here, go to the Table of Contents tab, add the complimentary introduction to your cart, and confirm your order.

RSS Feeds – Pharmaceuticals

SUMMARY FIGURE  

GLOBAL MARKET FOR TREATMENTS FOR SYNDROMES OF DEMENTIA AND MOVEMENT DISORDERS, 2010-2017 

($ MILLIONS)

Source: BCC Research